Retention · healthcare · BeneluxJul 202610 min read367 words

Retention and expansion for Series B companies: scaling without breaking for healthcare and life sciences in the Benelux region

How Series B companies scale retention and expansion across regions and teams without losing the discipline that made it work at Series A. Written for commercial leaders at healthtech, medtech, and life-sciences companies in the Benelux region.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in the Benelux region. In this market, Benelux buyers reward multilingual specificity and a pitch that respects local nuance, so the way you install retention and expansion has to be shaped to that reality from day one.

Series B is the stress test for retention and expansion. What worked at fifteen people fails at fifty unless the operating rhythm is deliberate.

The Series B move is to separate the model owner from the operators. One senior human owns strategy, gross and net revenue retention, and the weekly review; a small team runs the machine.

Add a second geography or segment only when the first one is producing a defensible number for two full quarters. Not before.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in the Benelux region it is compounded by the fact that local nuance and language fit, not scale is what actually gates growth. Retention and expansion is only useful here when it is pointed at both constraints at once.

Governance appears at Series B — that is fine, provided it accelerates rather than slows. The test is whether reviews still make decisions or just distribute updates.

The Series B failure mode of retention and expansion is treating CS as a support cost centre, amplified by headcount. Fix the root cause; do not paper over it with more people.

Compensation begins to matter now. Pay operators on gross and net revenue retention outcomes, not on effort. Effort-based comp at Series B produces theatre.

A well-run retention and expansion function at Series B is the moat that survives to Series C. Companies that skip this discipline burn through raises trying to buy it back.

Concretely for healthcare and life sciences in the Benelux region: the healthcare teams that install this get past procurement instead of dying in it, and one anchored Benelux customer becomes the reference the rest of the region asks for. That is the reason it is worth installing retention and expansion deliberately for this market rather than importing a playbook designed for somewhere else.

net revenue retentionSaaS expansionchurn reductionnet revenue retention for series Bscaling GTMnet revenue retention for healthcare and life sciencesnet revenue retention in the Benelux regionhealthcare and life sciences growth in the Benelux region

Frequently asked questions

Retention · healthcare · Benelux — answered

Does retention and expansion work for healthcare and life sciences in the Benelux region?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in the Benelux region, Benelux buyers reward multilingual specificity and a pitch that respects local nuance. The healthcare teams that install this get past procurement instead of dying in it.
How does retention and expansion change at Series B?
Ownership separates from execution; operating rhythm gets more deliberate; governance appears.
When should we expand to a second region?
After the first region delivers two straight quarters of defensible gross and net revenue retention.
What compensation model works for retention and expansion operators at Series B?
Outcome-linked on gross and net revenue retention, not activity-based.
What is the Series B stress point?
Treating CS as a support cost centre, amplified by headcount. Fix the root, not the symptom.
What is the Benelux-specific pitfall when running retention and expansion for healthcare?
Importing a playbook that was built for another market. In the Benelux region, Benelux buyers reward multilingual specificity and a pitch that respects local nuance — the install has to reflect that.

Growth Broker editorial

Filed under retention · healthcare · benelux

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call